UBS Group’s Progyny PGNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.36M Buy
374,444
+245,357
+190% +$5.26M ﹤0.01% 3810
2025
Q4
$3.31M Sell
129,087
-114,454
-47% -$2.63M ﹤0.01% 4450
2025
Q3
$5.24M Buy
243,541
+94,045
+63% +$2.14M ﹤0.01% 3983
2025
Q2
$3.29M Buy
149,496
+32,221
+27% +$707K ﹤0.01% 4309
2025
Q1
$2.62M Sell
117,275
-159,915
-58% -$3.44M ﹤0.01% 4459
2024
Q4
$4.78M Sell
277,190
-116,491
-30% -$1.81M ﹤0.01% 3900
2024
Q3
$6.6M Buy
393,681
+329,047
+509% +$7.9M ﹤0.01% 2783
2024
Q2
$1.85M Sell
64,634
-50,910
-44% -$1.53M ﹤0.01% 3848
2024
Q1
$4.41M Buy
115,544
+75,247
+187% +$2.84M ﹤0.01% 3104
2023
Q4
$1.5M Buy
40,297
+9,318
+30% +$313K ﹤0.01% 4113
2023
Q3
$1.05M Buy
30,979
+21,457
+225% +$810K ﹤0.01% 4019
2023
Q2
$375K Sell
9,522
-716
-7% -$25.8K ﹤0.01% 5063
2023
Q1
$329K Sell
10,238
-563
-5% -$18.6K ﹤0.01% 5007
2022
Q4
$336K Sell
10,801
-70,095
-87% -$2.53M ﹤0.01% 5024
2022
Q3
$3M Buy
80,896
+70,000
+642% +$2.62M ﹤0.01% 2805
2022
Q2
$317K Sell
10,896
-4,177
-28% -$150K ﹤0.01% 4593
2022
Q1
$775K Sell
15,073
-2,842
-16% -$122K ﹤0.01% 4349
2021
Q4
$902K Sell
17,915
-8,825
-33% -$494K ﹤0.01% 4483
2021
Q3
$1.5M Sell
26,740
-52,675
-66% -$2.91M ﹤0.01% 3835
2021
Q2
$4.69M Buy
79,415
+28,432
+56% +$1.6M ﹤0.01% 2747
2021
Q1
$2.27M Buy
50,983
+23,046
+82% +$1.08M ﹤0.01% 3439
2020
Q4
$1.18M Buy
27,937
+4,029
+17% +$131K ﹤0.01% 3873
2020
Q3
$703K Buy
23,908
+2,050
+9% +$56.5K ﹤0.01% 3903
2020
Q2
$564K Buy
21,858
+16,315
+294% +$375K ﹤0.01% 4032
2020
Q1
$118K Sell
5,543
-23,569
-81% -$648K ﹤0.01% 5143
2019
Q4
$799K Buy
+29,112
New +$698K ﹤0.01% 4417

Other funds holding PGNY

UBS Group's PGNY Position: Q1 2026 in Review

UBS Group increased its Progyny (PGNY) stake by 190% in Q1 2026, buying an estimated $5.26M and bringing the position to 374,444 shares worth $6.36M. The position accounts for ﹤0.01% of the portfolio, ranked #3810.

UBS Group first reported a position in PGNY in Q4 2019 and has held it in 26 quarters since. The position peaked at $6.6M in Q3 2024. 291 funds tracked by Wall St. Rank hold PGNY as of Q1 2026.

  • UBS Group held 374,444 shares of Progyny worth $6.36M as of Q1 2026.
  • UBS Group bought 245,357 Progyny shares in Q1 2026, an estimated $5.26M.
  • Progyny made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #3810 holding.
  • UBS Group first reported a position in Progyny in Q4 2019 and has held it in 26 quarters since.
  • UBS Group's Progyny position peaked at $6.6M in Q3 2024.
  • 291 funds tracked by Wall St. Rank held Progyny as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.